sensitivity in the clinical diagnosis of melanoma from 60 to 90% with specificity as high as 95% [2] . However, melanoma may be clinically but also dermoscopically indistinguishable from melanocytic nevi making early recognition a diagnostic challenge [3] , especially in incipient lesions. Furthermore, overlap of clinical features may lead to overlooking MMs and excising an excessive number of benign lesions [4] . Dermoscopic documentation of melanocytic lesions for the comparison of current and previous images in search of subtle changes over time, namely digital follow-up (DFU), has shown to be helpful in the diagnosis of early melanomas which might lack of specific criteria for malignancy. This approach has proved to be efficient in detecting early MMs without increasing the number of unnecessary excisions [5] [6] [7] .
The use of baseline regional photographs, so-called total body photography (TBP), might facilitate the detection of new lesions, and visual changes in pre-existing lesions, by providing a comparative reference for subsequent examinations [8] .
The combined use of TBP and digital dermoscopy, called the ''two-step method'' of digital follow-up [9] , has been proposed an approach for the assessment of individuals at high risk, being potentially more accurate than the two strategies separately since it allow not only for the detection of MM with few dermoscopic criteria by comparison of dermoscopy records, but also for the detection of melanoma either presented as new lesions or arising from nevi that were not monitored by dermoscopy [10] . The inclusion of patients who are at high risk for melanoma in follow-up programs allows the detection of melanomas in early stages, with good prognosis, even in the absence of clinical and dermoscopic features of melanoma [11] .
The aim of this study was to assess the clinical, dermoscopic and histologic features of melanomas diagnosed with the use of dermoscopy during routine skin examinations and the use of digital dermoscopy monitoring, compared with those melanomas that led to patient's consultation.
Methods
We conducted a retrospective analysis of clinical and dermoscopic characteristics of 99 melanomas consecutively diagnosed over a 4-year period at the Dermatology Department of the Hospital Provincial del Centenario de Rosario, a third level hospital, and at the skin cancer department of a private diagnostic center. The study included primary lesions with clinical and dermoscopic pictures of acceptable quality to allow reliable evaluation. Patients who were referred with diagnosis of melanoma after excision or biopsy (incisional or excisional) were excluded from the study as well as melanoma recurrences or cutaneous metastases of prior melanomas.
All melanomas diagnosed between January 2010 and December 2013 that met inclusion criteria for the study were collected from both databases. The MMs were divided into 3 groups: 1) the MM was the reason for consultation (Melanoma consultation, MMC), 2) the MM was detected during routine control of nevi using dermoscopy (Melanoma routine control, MMRC) and 3) the MM was detected due to changes For the clinical evaluation of the lesions, the ABCD clinical acronym for early detection of melanoma was used [11] .
The dermoscopic evaluation was performed using the ABCD rule of dermoscopy proposed by Stolz, which is based on the evaluation of 4 criteria: asymmetry (A), abrupt borders (B), colors (C), and different dermoscopic structures (D) [13] . The total dermoscopy score (TDS) was calculated in each lesion, and they were classified as benign, suspicious or malignant. 
Statistical Analysis
The x 2 test was used to compare qualitative variables, applying Fisher correction when needed because of the small sample size in tables of 2x2, and the t test was used to compare means. Differences were considered to be statistically significant at P ≤ .05.
Results
Of the melanomas diagnosed between January 2010 and December 2013, 99 fulfilled the inclusion criteria of the study, 35 (35.3%) were the reason for patient consultation (MMC), 52 (52.5%) were detected during routine control of nevi using dermoscopy (MMRC), and 12 (12.2%) were detected due to changes observed during digital dermoscopy follow-up (MMDFU).
Population
The study population consisted of 40 female (45%) and 49 male (55%), with a mean age of 50.8 (18-93) years. The distribution according to gender was homogeneous among the three groups.
Clinical evaluation
Most of the MM that led to patient's consultation (MMC)
were clinically asymmetric, had irregular borders and multiple colors, and had a diameter larger than 6 mm (Table 1) .
Of the MMRC, near 60% were asymmetric and had multiple colors, half had irregular borders, and more than 70% were 6 mm or larger. A quarter of the MMDFU were asymmetric, only 16.6% had irregular borders, about 40% had multiple colors and half of them were larger than 6 mm.
Almost 75% of the MMC fulfilled the 4 ABCD criteria, while a third of the MMRC and just 8% of the MMDFU ( Figure 1 ). All differences were statistically significant.
Dermoscopic evaluation
Classification according to the ABCD rule of dermoscopy is shown in Figure 2 ).
The most frequent morphological change was asymmetric enlargement in 6 out of 12 MMDFU, focal changes in structure were seen in 3 of 12 of the cases and regression in 1 of 12.
One MM was excised because of symmetric enlargement and absence of other significant changes (Figure 3 ). One MM was excised because was noted as a new lesion in the comparative analysis of consecutive total body photographs.
Histology evaluation
The percentages of in situ melanoma among the groups were (Table 3) .
Clinical stage at diagnosis
The clinical stage of the melanomas was classified according to the American Joint Committee on Cancer staging system [14] . 
Discussion
Early recognition is the most effective intervention to improve melanoma prognosis [1] . Over the past decades, efforts in secondary prevention have contributed to the stabilization of melanoma mortality.
The ABCD acronym was designed almost 30 years ago to provide the general public and primary care professionals a memorable and useful tool to aid in the early recognition of melanoma [12] . The parameters asymmetry, border irregularity, color (multiple colors), and diameter larger than 6 mm are used globally in medical education and in the lay press to provide simple parameters for evaluation of pigmented skin lesions which may require a more comprehensive examination by a specialist. While the A, B, and C criteria have been widely accepted, the emergence of reports with a significant proportion of melanomas with a diameter < 6 mm [15, 16] , has generated controversy around the criterion D, questioning its usefulness in recognizing incipient lesions. In our study, the vast majority of the melanomas that led to patient's consultation (MMC) fulfilled the 4 ABCD criteria with a 97% of lesions with a diameter > 6 mm. More than 70%
of the MMRC had a diameter > 6 mm; one third of theses melanomas fulfilled the 4 ABCD criteria simultaneously.
In the MMDFU group, melanomas most melanomas were symmetric and did not have irregular borders, only 40%
had multiple colors and only half had a diameter > 6 mm.
Less than 10% of the MMDFU fulfilled the 4 ABCD criteria simultaneously. In 2004, the ABCD acronym was revised, the addition of E, for evolution, has substantially improved the ability of clinicians and the general population to detect melanomas at an early stage by recognizing their natural dynamics. The latter criterion is especially important for the diagnosis of nodular melanoma, which frequently, at least initially, is symmetrical, with regular borders and few colors [17] .
Dermoscopy has been shown to improve the diagnostic accuracy for early melanoma detection [18] [19] [20] , and currently training and utilization of dermoscopy is recommended for clinicians routinely examining pigmented skin lesions [21] .
Most melanomas that led to patient's consultation were already clinically suspicious (3/4 fulfilled the 4 ABCD criteria) and more than 80% were correctly classified as malignant according to ABCD rule of dermoscopy, with less than 6% misclassified as benign. In the MMRC group, near 40% of the melanomas were correctly classified as malignant, with a significant proportion of melanomas misclassified and benign or suspicious (almost 10% and 50% respectively). These findings support the recommendation that dermoscopy should be used for all lesions, and not just for those suspicious from the clinical point of view [22] , since melanomas detected in this group corresponded to lesions that the patient was unaware of at the time of consultation or lesions that didn't caught patient's attention previously. In a recent study, Salerni et al It has been reported that melanoma may simulate benign melanocytic nevi even under dermoscopy examination [3] .
On the basis that benign lesions remain stable whereas melanoma tend to change over time, digital follow-up of melanocytic lesions has been proposed as a strategy to recognize melanomas that may lack distinct dermoscopic features at baseline [23] . In our study, 11 of the 12 MMDFU where detected only due to changes observed during digital followup. In this group, only one third of the melanomas were correctly classified as malignant according to the ABCD rule of dermoscopy, with a mean TDS of 4.77 (significantly lower than the MMC and MMRC group), pointing out that digital follow-up allow for the detection of early melanoma, when specific structures or criteria for malignancy may not be present yet. Similarly, in the ten-year experience in the surveillance of high-risk melanoma patients in a melanoma unit [10, 24] , 98 melanomas were diagnosed, with less than half correctly classified as malignant according to dermoscopy algorithm.
Breslow thickness of the primary tumor is the dominant prognostic factor in melanoma. Criscione and Weinstock [25] , analyzed data from the Surveillance Epidemiology and End Result (SEER) program of the National Cancer Institute, they found that the most substantial change across the past decades occurred in the proportion of melanoma in situ, which rose from 25% in 1988 to 38% in 2006. In our study, proportion of melanoma in situ varies according to the observed group: less than one quarter among the melanomas that led to patient's consultation, but rising to 50% almost 60% with the use of dermoscopy and digital dermoscopy respectively; highlighting the benefits of the latter approaches in the recognition of melanoma at early stages.
Regarding this issue, a meta-analysis was recently conducted to assess the evidence of follow-up of melanocytic skin lesions with digital dermoscopy in the management of individuals at risk for melanoma [26] . This analysis provided 
